Cargando…
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133073/ https://www.ncbi.nlm.nih.gov/pubmed/34026158 http://dx.doi.org/10.1002/ccr3.4118 |
_version_ | 1783695013871353856 |
---|---|
author | Yamaoka, Keiko Nagashima, Shuichi Okada, Nobukazu Sawayama, Nagisa Saito, Shinsuke Takahashi, Manabu Okada, Kenta Endo, Kazuhiro Koizumi, Masaru Sasanuma, Hideki Ebihara, Ken Kasajima, Atsuko Fukushima, Noriyoshi Sata, Naohiro Ishibashi, Shun |
author_facet | Yamaoka, Keiko Nagashima, Shuichi Okada, Nobukazu Sawayama, Nagisa Saito, Shinsuke Takahashi, Manabu Okada, Kenta Endo, Kazuhiro Koizumi, Masaru Sasanuma, Hideki Ebihara, Ken Kasajima, Atsuko Fukushima, Noriyoshi Sata, Naohiro Ishibashi, Shun |
author_sort | Yamaoka, Keiko |
collection | PubMed |
description | Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR. |
format | Online Article Text |
id | pubmed-8133073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81330732021-05-21 A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide Yamaoka, Keiko Nagashima, Shuichi Okada, Nobukazu Sawayama, Nagisa Saito, Shinsuke Takahashi, Manabu Okada, Kenta Endo, Kazuhiro Koizumi, Masaru Sasanuma, Hideki Ebihara, Ken Kasajima, Atsuko Fukushima, Noriyoshi Sata, Naohiro Ishibashi, Shun Clin Case Rep Case Reports Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR. John Wiley and Sons Inc. 2021-05-19 /pmc/articles/PMC8133073/ /pubmed/34026158 http://dx.doi.org/10.1002/ccr3.4118 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Yamaoka, Keiko Nagashima, Shuichi Okada, Nobukazu Sawayama, Nagisa Saito, Shinsuke Takahashi, Manabu Okada, Kenta Endo, Kazuhiro Koizumi, Masaru Sasanuma, Hideki Ebihara, Ken Kasajima, Atsuko Fukushima, Noriyoshi Sata, Naohiro Ishibashi, Shun A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
title | A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
title_full | A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
title_fullStr | A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
title_full_unstemmed | A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
title_short | A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
title_sort | case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133073/ https://www.ncbi.nlm.nih.gov/pubmed/34026158 http://dx.doi.org/10.1002/ccr3.4118 |
work_keys_str_mv | AT yamaokakeiko acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT nagashimashuichi acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT okadanobukazu acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT sawayamanagisa acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT saitoshinsuke acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT takahashimanabu acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT okadakenta acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT endokazuhiro acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT koizumimasaru acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT sasanumahideki acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT ebiharaken acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT kasajimaatsuko acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT fukushimanoriyoshi acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT satanaohiro acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT ishibashishun acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT yamaokakeiko caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT nagashimashuichi caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT okadanobukazu caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT sawayamanagisa caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT saitoshinsuke caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT takahashimanabu caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT okadakenta caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT endokazuhiro caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT koizumimasaru caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT sasanumahideki caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT ebiharaken caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT kasajimaatsuko caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT fukushimanoriyoshi caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT satanaohiro caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT ishibashishun caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide |